Regulators urged to approve game-changing new Alzheimer’s drug that slows decline by up to 60%…
Britain's regulators are being urged to rapidly approve new Alzheimer's drugs that have been hailed as a 'turning point' in the fight against the disease.Donanemab was found to significantly delay the worsening of symptoms in people with…